Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of ESRRG mRNA | increases expression | 19933214
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and affects the activity of ESRRG protein | affects activity|affects binding | 16889744
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 17049190 18197296 11447273 14751226
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and results in decreased activity of [ESRRG protein binds to ESRRA protein] | affects binding|decreases activity | 14751226
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen inhibits the reaction [ESRRG protein binds to NCOA1 protein] | affects binding|decreases reaction | 11447273
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | affects binding|decreases reaction | 16889744
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased activity of ESRRG protein | decreases activity | 15149736
|
C016601 |
4-hydroxytamoxifen |
bisphenol A inhibits the reaction [4-hydroxytamoxifen binds to and results in decreased activity of ESRRG protein] | affects binding|decreases activity|decreases reaction | 18197296
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 15161930
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 16515477
|
C062262 |
4-hydroxytoremifene |
4-hydroxytoremifene results in decreased activity of ESRRG protein | decreases activity | 15149736
|
C062262 |
4-hydroxytoremifene |
4-hydroxytoremifene binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 16515477
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ESRRG mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ESRRG protein | affects expression | 20106945
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of ESRRG mRNA | increases expression | 20458559
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of ESRRG mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ESRRG mRNA | decreases expression | 20106945
|
C004541 |
biochanin A |
biochanin A promotes the reaction [ESRRG protein binds to PNRC1 protein] | affects binding|increases reaction | 14638870
|
C006780 |
bisphenol A |
bisphenol A analog binds to ESRRG protein | affects binding | 18197296
|
C006780 |
bisphenol A |
bisphenol A binds to and results in increased activity of ESRRG protein | affects binding|increases activity | 20427257
|
C006780 |
bisphenol A |
bisphenol A binds to ESRRG protein | affects binding | 19304792 18197296
|
C006780 |
bisphenol A |
bisphenol A inhibits the reaction [4-hydroxytamoxifen binds to and results in decreased activity of ESRRG protein] | affects binding|decreases activity|decreases reaction | 18197296
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ESRRG mRNA | decreases expression | 20106945
|
C004742 |
daidzein |
daidzein promotes the reaction [ESRRG protein binds to PNRC1 protein] | affects binding|increases reaction | 14638870
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ESRRG mRNA | affects cotreatment|decreases expression | 18606552
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of ESRRG mRNA | increases expression | 18042831
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and affects the activity of ESRRG protein | affects activity|affects binding | 16889744
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 11559547 14751226
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in increased activity of ESRRG protein | affects binding|increases activity | 12579585
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to ESRRG protein | affects binding | 11447273 17049190
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol inhibits the reaction [ESRRG protein results in increased expression of TFF1 mRNA] | decreases reaction|increases expression | 11559547
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 15161930
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in increased activity of ESRRG protein | affects binding|increases activity | 12579585
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in decreased activity of ESRRG protein | affects binding|decreases activity | 16515477
|
D019833 |
Genistein |
Genistein promotes the reaction [ESRRG protein binds to PNRC1 protein] | affects binding|increases reaction | 14638870
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ESRRG mRNA | affects cotreatment|decreases expression | 18606552
|
C501618 |
N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide |
N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide binds to and results in increased activity of ESRRG protein | affects binding|increases activity | 15713377
|
C041786 |
palm oil |
palm oil results in increased expression of ESRRG mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ESRRG mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ESRRG mRNA | increases expression | 18301758
|
D013629 |
Tamoxifen |
Tamoxifen binds to and affects the activity of ESRRG protein | affects activity|affects binding | 16889744
|
D013629 |
Tamoxifen |
Tamoxifen binds to ESRRG protein | affects binding | 11447273
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | affects binding|decreases reaction | 16889744
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of ESRRG mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ESRRG mRNA | affects binding|increases expression | 16214954
|
C012589 |
trichostatin A |
trichostatin A results in increased activity of ESRRG protein | increases activity | 11705994
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ESRRG mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.66 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.94 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.84 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.84 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
9.84 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.84 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.54 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.26 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.26 | 16835633 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.30 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.78 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.65 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.49 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.88 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.70 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.28 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.28 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.28 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.60 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.64 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.69 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.65 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.65 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
3.65 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
3.65 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
3.65 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.65 | 18425577 19189210 20859285 19142967 17242785 19221464 19066611 16202921 21138602 18815881 19288272 15668708 16873071 18351453 20065188 19011961 19289846 17049068 21152245 17440819 17261762 19115204 19200415 17893378 20005174 20544844 18821012 19189212 18997820 19487384 18984771 19155303 19410462 18629630 16818667 15565566 20390343 19084267 19103187 18855134 19059307 20135344 11161223 19244106 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.65 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.15 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.32 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
10.98 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.98 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
10.98 | 16217749 11135700 14691202 15073043 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
10.98 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
10.98 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.98 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.80 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.68 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.95 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.00 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.45 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.26 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.59 | 10591146 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
7.36 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.36 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.47 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.40 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.00 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.29 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.29 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.26 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.00 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.41 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.41 | 15322242 10048152 20055451 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
10.76 | 12952375 16002989 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
10.76 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.92 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.17 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.34 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
6.99 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.99 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.99 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.37 | 12153990 16177239 19420014 18713872 12540782 19739265 14550746 10915739 15619225 16227642 10774834 15968718 10663392 16781746 12392966 18071297 11529661 16109766 2444490 11739529 19164858 19085960 12594235 11834606 12958197 19416960 16485898 14986274 16393943 12705907 11421492 14725611 19923254 11287661 17522070 11743745 19370779 11461765 17562736 16081117 17906064 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.37 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.91 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.08 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
8.08 | 7515130 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.32 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.97 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.97 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.71 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.36 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.45 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
11.25 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
11.25 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
22.07 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
22.07 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
22.07 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
22.07 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
22.07 | 16202921 17893378 19155303 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.86 | 9294722 10568697 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.83 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.27 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.27 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
28.47 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
28.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
28.47 | 17967931 18296743 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
28.47 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
28.47 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
28.47 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
7.83 | 16513791 16002989 16534752 15751030 16611131 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
7.83 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.27 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.99 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
13.62 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.62 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.08 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.48 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.74 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.11 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.75 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.03 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
biochanin A |
11.48 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
11.48 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
11.48 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.40 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.12 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.12 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.42 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.23 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.16 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.63 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.63 | 15340226 16120746 12621046 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.24 | 17457083 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.55 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.55 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.42 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.02 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.44 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.25 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.26 | 10903974 |
MESH:D006973 |
Hypertension |
|
daidzein |
8.26 | 17169123 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.26 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.39 | 16002989 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.17 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
2.92 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.70 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.70 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.70 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.62 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
11.62 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.62 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.25 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.43 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.43 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.54 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
11.54 | 15003126 16762066 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.54 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.87 | 17184923 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.12 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.12 | 18980019 17468513 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.62 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.11 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.29 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.59 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.06 | 17050201 20471514 19850784 16968895 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.06 | 18206229 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.09 | 11468182 16823087 15336539 19642359 17217047 17649720 17107899 17712046 16112521 19075265 12018890 9834237 17869043 19035177 19225113 12712474 16966277 15213294 12679006 16891316 15748426 16331271 11161223 16330433 15622746 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.17 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.54 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.02 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.77 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
4.74 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.74 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.74 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.74 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 16611625 12587719 12969438 11587558 19460945 19784758 19014921 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.07 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.79 | 15890375 18177683 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
20.79 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.79 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
20.79 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.79 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
20.79 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.14 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.14 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.14 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.21 | 15213294 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.84 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.32 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.32 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.32 | 17053015 18816296 18520028 20464547 20869020 6695378 20064080 20135361 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.32 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.32 | 11884234 19555203 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.96 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
7.73 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
7.73 | 8764131 17941976 11980663 9488045 9205081 8840982 18798262 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.32 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.57 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
5.71 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.71 | 11731420 19196723 14580682 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.35 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.48 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.48 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.99 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.38 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.11 | 18303189 16966607 16166281 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.59 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.04 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.12 | 15949261 14977855 19417148 11468182 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
7.12 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.32 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.48 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.03 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.41 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.41 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.87 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.91 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.91 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.78 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.47 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.69 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
7.69 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.69 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
4.91 | 9205081 9488045 8764131 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.81 | 19196722 19189210 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.25 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.12 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
21.95 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
21.95 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
21.95 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.95 | 14600291 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.12 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
2.99 | 10525206 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.72 | 18514411 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.27 | 19632207 17217161 20518802 21332399 18457598 20132043 18674790 11836018 16723640 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.27 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.14 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.91 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.80 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.68 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.68 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
7.68 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.24 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.36 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.36 | 19294695 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.98 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.06 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
10.32 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
10.32 | 18606552 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.98 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.48 | 15687265 16977796 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.70 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.37 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.06 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
21.67 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
21.67 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
21.67 | 11222880 11118676 11399792 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
21.67 | 18042343 18220299 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.06 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.74 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.03 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.42 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.42 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
biochanin A |
2.42 | 12111696 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.42 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.42 | 17136230 15846301 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.42 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.42 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.42 | 19789329 18798265 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.74 | 18629315 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.59 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.96 | 15814490 17365031 17975199 17322281 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.65 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.78 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.18 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.18 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
11.20 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.20 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.85 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.32 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.32 | 20155912 2093021 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.79 | 16045194 16684133 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.71 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
2.94 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.77 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
11.32 | 12973940 11780464 12845720 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.32 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
11.32 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.32 | 8653321 16712894 17572228 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.80 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
3.87 | 16175088 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
13.17 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
13.17 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.89 | 15809267 16690809 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.79 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.25 | 16513791 16002989 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.40 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.06 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.58 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.25 | 17120751 |